Results 191 to 200 of about 97,243 (298)

Improving outcomes of patients with severe respiratory and circulatory failure following living donor liver transplantation: efficacy of extracorporeal membrane oxygenation. [PDF]

Hepatobiliary Surg Nutr
Soyama A, Sekino M, Hara T, Eguchi S.
europepmc   +1 more source

Intravascular Lithotripsy Is Associated With Superior Clinical Outcomes Compared to Atherectomy: A Large‐Scale, Propensity‐Matched Analysis

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Coronary artery disease (CAD) with severe calcification remains a growing challenge in percutaneous coronary intervention (PCI). Atherectomy (ATH) has long been used for plaque modification, whereas intravascular lithotripsy (IVL) has emerged as a promising alternative. Large‐scale comparative data on long‐term outcomes are limited.
Charles D. Miks, Grant K. Ozaki, Chirayu R. Shukla, Vikram Sharma   +3 more
wiley   +1 more source

Fulminant Lyme Carditis With Rapid Hemodynamic Deterioration in an Adolescent: A Case Report. [PDF]

Cureus
Enaimi M, Elbouti A, Hammadi H, Babour S, Kartite N, Houba A, Hicham B, Doghmi N.   +7 more
europepmc   +1 more source

Engineering Lipid Nanoparticles for Precision RNA Delivery: Design Principles, Targeting Strategies, and Clinical Prospects

Cancer Nexus, EarlyView.
ABSTRACT Lipid nanoparticles (LNPs) represent the most clinically advanced platform for RNA delivery and have enabled major breakthroughs in vaccines and gene therapies. However, their broader application is still limited by inefficient extrahepatic delivery, immunogenicity, and insufficient control over tissue‐ and cell‐specific targeting. This review
Yu Han, Ying Wang, Xintao Gao, Yan Lei, Yantao Li, Zhiyong Tang   +5 more
wiley   +1 more source

Diagnostic and Prognostic Value of Arterial Blood Gas and Electrolyte Analyses in Heart Failure. [PDF]

Rev Cardiovasc Med
Tetaj N, Segreti A, Piccirillo F, Pelullo M, Crispino SP, Ciancio M, Ussia GP, Grigioni F.   +7 more
europepmc   +1 more source

Oral Squamous Cell Carcinoma‐Risk Factors, Diagnosis, Treatment, and Prevention

Cancer Nexus, EarlyView.
ABSTRACT Oral squamous cell carcinoma (OSCC) usually originates from the precancerous lesions of oral mucosa and accounts for approximately 90% of oral cancers. In‐depth understanding of pathogenesis, hallmarks, and etiological factors is a crucial prerequisite for advancing the diagnosis and treatment for OSCC patients. This review aims to present the
Liping Wang, Xiaole Liu, Mengjie Chen, Ying Hu, Lilei Zhu   +4 more
wiley   +1 more source

A rare case of obstructive shock caused by a giant biloma with right heart compression in a patient undergoing hemodialysis. [PDF]

CEN Case Rep
Oda H, Ohashi T, Hayakawa A, Tanaka H, Takagi M, Higuchi S, Kumazawa H.   +6 more
europepmc   +1 more source

Promoting Sustainability in Healthcare: Unraveling the Mechanism of Diversity's Impact in the Pharmaceutical Sector

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT Although research on sustainability in the healthcare sector is growing, limited attention has been paid to how pharmaceutical companies can be motivated to engage more actively in achieving net‐zero healthcare goals. This study argues that the breadth of directors' experiences—across educational, industrial, and organizational domains—can ...
Ruixin Su, Jianguo Du, Si Li
wiley   +1 more source

Diagnosis and treatment strategies for cardiogenic shock in Takotsubo syndrome with a temporary left ventricular assist device-A single-center study. [PDF]

JHLT Open
Huang A, von Mackensen JKR, Zwaans VIT, Schuering CL, Iske J, Pitts L, Kaemmel J, Nersesian G, Chiu CY, Starck CT, Kempfert J, Jacobs S, Falk V, Potapov EV, Wert L.   +14 more
europepmc   +1 more source

Market Perceptions of ESG Reputational Risk in the US Pharmaceutical Industry

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT Negative ESG‐related reputational events generate significant corporate risks, particularly within sensitive sectors such as the pharmaceutical industry. Using novel reputational data, this research investigates investor perceptions of the consequences of experienced ESG breaches among US pharmaceutical firms.
Erdinc Akyildirim, Shaen Corbet, Jose Antonio Muñiz, Frank Scrimgeour   +3 more
wiley   +1 more source